David Larsen
Stock Analyst at BTIG
(1.94)
# 2,912
Out of 4,784 analysts
74
Total ratings
31.58%
Success rate
-4.19%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $29.14 | +20.11% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $86.96 | +49.49% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $23.20 | +33.62% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $177.39 | +46.57% | 2 | Nov 1, 2024 | |
| SLP Simulations Plus | Maintains: Buy | $60 → $50 | $24.29 | +105.85% | 2 | Oct 24, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $18.03 | +10.93% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $30.54 | +129.21% | 1 | Oct 3, 2024 | |
| DH Definitive Healthcare | Initiates: Buy | $7 | $2.94 | +138.10% | 1 | Sep 17, 2024 | |
| PGNY Progyny | Downgrades: Neutral | n/a | $21.90 | - | 3 | Aug 7, 2024 | |
| VEEV Veeva Systems | Initiates: Buy | $240 | $234.21 | +2.47% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $2.64 | +165.15% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $5.45 | +156.88% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.17 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $35.01 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $58.51 | - | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $9.60 | +368.75% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $4.55 | +361.54% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $4.49 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.99 | - | 2 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.59 | +54.94% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.09 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $6.09 | +1,459.93% | 2 | Oct 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $7.82 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $136.44 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $668.06 | -76.05% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $11.19 | +525.56% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $68.62 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $67.14 | +26.60% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $8.58 | +168.07% | 1 | Nov 2, 2017 |
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $29.14
Upside: +20.11%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $86.96
Upside: +49.49%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $23.20
Upside: +33.62%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $177.39
Upside: +46.57%
Simulations Plus
Oct 24, 2024
Maintains: Buy
Price Target: $60 → $50
Current: $24.29
Upside: +105.85%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $18.03
Upside: +10.93%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $30.54
Upside: +129.21%
Definitive Healthcare
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $2.94
Upside: +138.10%
Progyny
Aug 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $21.90
Upside: -
Veeva Systems
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $234.21
Upside: +2.47%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $2.64
Upside: +165.15%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $5.45
Upside: +156.88%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.17
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $35.01
Upside: -
Oct 13, 2022
Initiates: Neutral
Price Target: n/a
Current: $58.51
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $9.60
Upside: +368.75%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $4.55
Upside: +361.54%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $4.49
Upside: -
Apr 29, 2022
Downgrades: Neutral
Price Target: n/a
Current: $6.99
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $22.59
Upside: +54.94%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $8.09
Upside: -
Oct 26, 2021
Maintains: Buy
Price Target: $80 → $95
Current: $6.09
Upside: +1,459.93%
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $7.82
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $136.44
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $668.06
Upside: -76.05%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $11.19
Upside: +525.56%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $68.62
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $67.14
Upside: +26.60%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $8.58
Upside: +168.07%